Boenning & Scattergood’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.71M Buy
7,064
+105
+2% +$28.1K 0.27% 96
2022
Q3
$1.57M Buy
6,959
+1
+0% +$242 0.32% 83
2022
Q2
$1.69M Sell
6,958
-106
-2% -$26K 0.32% 79
2022
Q1
$1.71M Sell
7,064
-24
-0.3% -$5.51K 0.27% 96
2021
Q4
$1.59M Sell
7,088
-29
-0.4% -$6.12K 0.25% 100
2021
Q3
$1.51M Sell
7,117
-49
-0.7% -$11.3K 0.27% 100
2021
Q2
$1.75M Buy
7,166
+71
+1% +$17.5K 0.3% 88
2021
Q1
$1.76M Buy
7,095
+527
+8% +$126K 0.34% 77
2020
Q4
$1.51M Buy
6,568
+199
+3% +$45.9K 0.32% 88
2020
Q3
$1.62M Buy
6,369
+365
+6% +$90.4K 0.39% 67
2020
Q2
$1.42M Buy
6,004
+806
+16% +$184K 0.38% 64
2020
Q1
$1.05M Buy
5,198
+125
+2% +$27.3K 0.36% 75
2019
Q4
$1.22M Buy
5,073
+70
+1% +$15.4K 0.32% 83
2019
Q3
$968K Buy
5,003
+125
+3% +$24K 0.28% 102
2019
Q2
$899K Sell
4,878
-200
-4% -$35.8K 0.26% 108
2019
Q1
$965K Buy
5,078
+200
+4% +$38.2K 0.29% 100
2018
Q4
$950K Buy
4,878
+300
+7% +$58.5K 0.33% 91
2018
Q3
$949K Buy
4,578
+120
+3% +$23.6K 0.3% 96
2018
Q2
$823K Buy
+4,458
New +$789K 0.27% 112

Other funds holding AMGN

Boenning & Scattergood's AMGN Position: Q4 2022 in Review

Boenning & Scattergood increased its Amgen (AMGN) stake by 1.5% in Q4 2022, buying an estimated $28.1K and bringing the position to 7,064 shares worth $1.71M. The position accounts for 0.27% of the portfolio, ranked #96.

Boenning & Scattergood first reported a position in AMGN in Q2 2018 and has held it in 19 quarters since. The position peaked at $1.76M in Q1 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Boenning & Scattergood held 7,064 shares of Amgen worth $1.71M as of Q4 2022.
  • Boenning & Scattergood bought 105 Amgen shares in Q4 2022, an estimated $28.1K.
  • Amgen made up 0.27% of Boenning & Scattergood's portfolio in Q4 2022, its #96 holding.
  • Boenning & Scattergood first reported a position in Amgen in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Amgen position peaked at $1.76M in Q1 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.